Your browser doesn't support javascript.
loading
ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung.
Nobre, Ana Rita; Dalla, Erica; Yang, Jihong; Huang, Xin; Wullkopf, Lena; Risson, Emma; Razghandi, Pedram; Anton, Melisa Lopez; Zheng, Wei; Seoane, Jose A; Curtis, Christina; Kenigsberg, Ephraim; Wang, Jianlong; Aguirre-Ghiso, Julio A.
Afiliação
  • Nobre AR; Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Department of Oncological Sciences, Black Family Stem Cell Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. LobatoCA@mskcc.org.
  • Dalla E; Abel Salazar Biomedical Sciences Institute, University of Porto, Porto, Portugal. LobatoCA@mskcc.org.
  • Yang J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. LobatoCA@mskcc.org.
  • Huang X; Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Department of Oncological Sciences, Black Family Stem Cell Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Wullkopf L; Department of Medicine, Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY, USA.
  • Risson E; Zhang Boli Intelligent Health Innovation Lab, Hangzhou, China.
  • Razghandi P; Department of Medicine, Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY, USA.
  • Anton ML; Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Department of Oncological Sciences, Black Family Stem Cell Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Zheng W; Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Department of Oncological Sciences, Black Family Stem Cell Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Seoane JA; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Curtis C; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Kenigsberg E; Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Department of Oncological Sciences, Black Family Stem Cell Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Wang J; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Aguirre-Ghiso JA; Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein College of Medicine, Bronx, NY, USA.
Nat Cancer ; 3(10): 1165-1180, 2022 10.
Article em En | MEDLINE | ID: mdl-36050483
ABSTRACT
Increasing evidence shows that cancer cells can disseminate from early evolved primary lesions much earlier than the classical metastasis models predicted. Here, we reveal at a single-cell resolution that mesenchymal-like (M-like) and pluripotency-like programs coordinate dissemination and a long-lived dormancy program of early disseminated cancer cells (DCCs). The transcription factor ZFP281 induces a permissive state for heterogeneous M-like transcriptional programs, which associate with a dormancy signature and phenotype in vivo. Downregulation of ZFP281 leads to a loss of an invasive, M-like dormancy phenotype and a switch to lung metastatic outgrowth. We also show that FGF2 and TWIST1 induce ZFP281 expression to induce the M-like state, which is linked to CDH1 downregulation and upregulation of CDH11. We found that ZFP281 not only controls the early dissemination of cancer cells but also locks early DCCs in a dormant state by preventing the acquisition of an epithelial-like proliferative program and consequent metastases outgrowth.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator 2 de Crescimento de Fibroblastos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator 2 de Crescimento de Fibroblastos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article